← Leaderboards
Cheng Zhang
Icahn School Of Medicine At Mount Sinai
$6,068,855
Attributed
$9,316,973
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,316,973 · 6
By mechanism
R01$5,027,786 · 2
R35$3,090,723 · 1
U01$633,135 · 1
R21$408,829 · 1
R03$156,500 · 1
Top collaborators
- Xiang-Qun Xie5 shared
- William Paul Duprex4 shared
- Yi Shi4 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Alex D. Federman$23,066,128
- Juan P Wisnivesky$34,328,417
- Amir Horowitz$1,902,078
- William Paul Duprex$23,556,651
- Yi Shi$3,269,966
Others in their field
Other Emerging Leaders on “Structure”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,827,589
- John Damon Chodera · Sloan-Kettering Inst Can Research$62,074,236
Research focus
StructureDrug DevelopmentBindingReportingPharmacologyAgonistLigandsComplexMolecularG-Protein-Coupled ReceptorsReceptorNovel TherapeuticsInflammatoryAntibodiesFamilyResolutionSmall MoleculeMolecular ConformationStructural BiologyBiologyInnovationInterestPropertyInsight
Grant awards (20)
Cannabinoid CB2 Receptor Structure and Allosteric Modulators$633,135
U01 · FY2025 · DA
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$535,044
R01 · FY2025 · AI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$419,909
R35 · FY2025 · GM · contact PI
Develop positive allosteric modulators to enhance XCR1 signaling in cancer$408,829
R21 · FY2025 · CA · contact PI
Cannabinoid CB2 Receptor Structure and Allosteric Modulators$633,135
R01 · FY2024 · DA
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$587,096
R01 · FY2024 · AI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$434,659
R35 · FY2024 · GM · contact PI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$231,205
R35 · FY2024 · GM · contact PI
Cannabinoid CB2 Receptor Structure and Allosteric Modulators$633,135
R01 · FY2023 · DA
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$614,795
R01 · FY2023 · AI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$769,010
R01 · FY2022 · AI
Cannabinoid CB2 Receptor Structure and Allosteric Modulators$631,607
R01 · FY2022 · DA
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$391,250
R35 · FY2022 · GM · contact PI
Cannabinoid CB2 Receptor Structure and Allosteric Modulators$623,964
R01 · FY2021 · DA
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$391,250
R35 · FY2021 · GM · contact PI
Structure and pharmacology of GPR32 in the resolution of inflammation$156,500
R03 · FY2021 · TR · contact PI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$391,250
R35 · FY2020 · GM · contact PI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$391,250
R35 · FY2019 · GM · contact PI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$48,700
R35 · FY2019 · GM · contact PI
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation$391,250
R35 · FY2018 · GM · contact PI